{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:04:42Z","timestamp":1782486282148,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Pacing and Electrophysiology Journal"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ipej.2026.02.013","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:56:10Z","timestamp":1771865770000},"page":"179-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ibutilide: what's clinically proven, what's being investigated?"],"prefix":"10.1016","volume":"26","author":[{"given":"Nevin","family":"Britto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithilesh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ipej.2026.02.013_bib1","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.15420\/aer.2025.33","article-title":"The global impact of atrial fibrillation","volume":"14","author":"Karatela","year":"2025","journal-title":"Arrhythmia Electrophysiol Rev"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1345\/aph.18097","article-title":"Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter","volume":"33","author":"Howard","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"2-3","key":"10.1016\/j.ipej.2026.02.013_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-5273(02)00380-7","article-title":"Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation","volume":"88","author":"de Paola","year":"2003","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ipej.2026.02.013_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/europace\/euw325","article-title":"Elucidation of hidden slow conduction by double ventricular extrastimuli: a method for further arrhythmic substrate identification in ventricular tachycardia ablation procedures","volume":"20","author":"Acosta","year":"2016","journal-title":"EP Europace"},{"issue":"2","key":"10.1016\/j.ipej.2026.02.013_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00005344-199202000-00014","article-title":"Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-Hour canine myocardial infarction","volume":"19","author":"Buchanan","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(92)90467-I","article-title":"Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium","volume":"222","author":"Cimini","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib7","first-page":"507","article-title":"Antiarrhythmic drug therapy in the treatment of atrial fibrillation","volume":"14","author":"Jung","year":"1996","journal-title":"Cardiol Clin"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)10779-9","article-title":"Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in Guinea pig ventricular cells","volume":"262","author":"Lee","year":"1992","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00005344-199307000-00002","article-title":"Antiarrhythmic and electrophysiologic effects of ibutilide in a chronic canine model of atrial flutter","volume":"22","author":"Buchanan","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"10.1016\/j.ipej.2026.02.013_bib11","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1540-8159.1993.tb00991.x","article-title":"Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization","volume":"16","author":"Nabih","year":"1993","journal-title":"Pacing Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.ipej.2026.02.013_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00232-019-00098-x","article-title":"Prevailing effects of ibutilide on fast delayed rectifier K+ channel","volume":"252","author":"Kodirov","year":"2019","journal-title":"J Membr Biol"},{"issue":"8","key":"10.1016\/j.ipej.2026.02.013_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9149(96)00560-7","article-title":"Electrophysiology and pharmacology of ibutilide","volume":"78","author":"Naccarelli","year":"1996","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ipej.2026.02.013_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12013-012-9385-7","article-title":"Effect of ibutilide on the Canine cardiac conduction system","volume":"64","author":"Sun","year":"2012","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"10.1016\/j.ipej.2026.02.013_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2165\/00003495-199754020-00010","article-title":"Ibutilide","volume":"54","author":"Foster","year":"1997","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0002-9149(97)00395-0","article-title":"Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function","volume":"80","author":"Stambler","year":"1997","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ipej.2026.02.013_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0002-9149(96)00565-6","article-title":"Efficacy of ibutilide for termination of atrial fibrillation and flutter","volume":"78","author":"Ellenbogen","year":"1996","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ipej.2026.02.013_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.CIR.97.5.493","article-title":"Ibutilide","volume":"97","author":"Murray","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ipej.2026.02.013_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10557-020-06958-2","article-title":"Ibutilide reduces ventricular defibrillation threshold and organizes ventricular fibrillation activation in canine heart failure model","volume":"34","author":"Zhang","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00005344-199504000-00005","article-title":"Acute intravenous conversion of canine atrial flutter","volume":"25","author":"Buchanan","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7","key":"10.1016\/j.ipej.2026.02.013_bib20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.02.013_bib21","series-title":"Corvert (ibutilide fumarate) injection [package insert]","author":"Pfizer","year":"2024"},{"issue":"12","key":"10.1016\/j.ipej.2026.02.013_bib22","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1592\/phco.28.12.1461","article-title":"Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction","volume":"28","author":"Tisdale","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"9151","key":"10.1016\/j.ipej.2026.02.013_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(98)04237-8","article-title":"Acute renal failure after ibutilide","volume":"353","author":"Franz","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ipej.2026.02.013_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-9926(199609)54:3<157::AID-TERA6>3.0.CO;2-0","article-title":"Developmental toxicity of ibutilide fumarate in rats after oral administration","volume":"54","author":"Marks","year":"1996","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005344-199310000-00006","article-title":"Comparative assessment of ibutilide, D-Sotalol, clofilium, E-4031, and UK-68, 798 in a rabbit model of proarrhythmia","volume":"22","author":"Buchanan","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ipej.2026.02.013_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(96)00566-8","article-title":"Safety and Risk\/Benefit analysis of ibutilide for acute conversion of atrial fibrillation\/flutter","volume":"78","author":"Kowey","year":"1996","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.100.4.369","article-title":"Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery","volume":"100","author":"VanderLugt","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.annemergmed.2017.07.481","article-title":"Ibutilide effectiveness and safety in the cardioversion of atrial fibrillation and flutter in the community emergency department","volume":"71","author":"Vinson","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"11","key":"10.1016\/j.ipej.2026.02.013_bib30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0002-9149(96)00010-0","article-title":"Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing","volume":"77","author":"Stambler","year":"1996","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ipej.2026.02.013_bib31","first-page":"212","article-title":"Efficacy and safety of ibutilide for conversion of atrial fibrillation\/flutter","volume":"42","author":"Yu","year":"2013","journal-title":"Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang University Medical sciences"},{"issue":"15","key":"10.1016\/j.ipej.2026.02.013_bib32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","article-title":"Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset","volume":"25","author":"Reisinger","year":"2004","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ipej.2026.02.013_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2006.07.017","article-title":"Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter","volume":"118","author":"Kafkas","year":"2007","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ipej.2026.02.013_bib34","first-page":"233","article-title":"Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department","volume":"19","author":"Simon","year":"2017","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.ipej.2026.02.013_bib35","first-page":"67","article-title":"Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation","volume":"21","author":"Vogiatzis","year":"2017","journal-title":"Hippokratia"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1573403X10666140513103709","article-title":"The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?","volume":"10","author":"Camm","year":"2014","journal-title":"Curr Cardiol Rev"},{"issue":"6","key":"10.1016\/j.ipej.2026.02.013_bib37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.79.6.568","article-title":"Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation","volume":"79","author":"Vos","year":"1998","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/europace\/eun302","article-title":"Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate","volume":"11","author":"Fragakis","year":"2008","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.ipej.2026.02.013_bib39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1540-8159.2007.00866.x","article-title":"Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter","volume":"30","author":"Tercius","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.ipej.2026.02.013_bib40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjcard.2010.04.020","article-title":"Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent","volume":"106","author":"Patsilinakos","year":"2010","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ipej.2026.02.013_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/hrt.2005.072322","article-title":"Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation","volume":"92","author":"Korantzopoulos","year":"2005","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2004.04.056","article-title":"Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter","volume":"44","author":"Chiladakis","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ipej.2026.02.013_bib43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000099059","article-title":"The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm","volume":"107","author":"Sideris","year":"2007","journal-title":"Cardiology"},{"issue":"9","key":"10.1016\/j.ipej.2026.02.013_bib44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/clc.4960250904","article-title":"Cardioversion of atrial fibrillation with ibutilide: when is it Most effective?","volume":"25","author":"Das","year":"2002","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.ipej.2026.02.013_bib45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9149(99)00619-0","article-title":"Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter","volume":"85","author":"Zaqqa","year":"2000","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.ipej.2026.02.013_bib46","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/hc4101.097538","article-title":"Electrophysiological effects of ibutilide in patients with accessory pathways","volume":"104","author":"Glatter","year":"2001","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ipej.2026.02.013_bib47","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/eurheartj\/ehw003","article-title":"The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study)","volume":"37","author":"Singh","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Indian Pacing and Electrophysiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629226000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629226000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:52:23Z","timestamp":1775541143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0972629226000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0972629226000598"],"URL":"https:\/\/doi.org\/10.1016\/j.ipej.2026.02.013","relation":{},"ISSN":["0972-6292"],"issn-type":[{"value":"0972-6292","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibutilide: what's clinically proven, what's being investigated?","name":"articletitle","label":"Article Title"},{"value":"Indian Pacing and Electrophysiology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ipej.2026.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Heart Rhythm Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}